| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for treating or preventing neuraminidase-resistant rotaviral infection in an individual. The agent for treating or preventing neuraminidase-resistant rotaviral infection in the individual specified in: one or more conjugated linoleic acid (CLA) isomers, vaccenic acid, high-CLA milk fat or fractions thereof, or a cow's milk fat compositions specified in: milk fat, anhydrous milk fat (AMF), phospholipid milk fat fractions high in phospholipids, milk fat fractions high in gangliosides. Using the agent for preparing the composition for treating and preventing neuraminidase-resistant rotaviral infection in the individual. A method of treating and preventing neuraminidase-resistant rotaviral infection in the individual involving administering an effective amount of the agent into the individual in need thereof.EFFECT: agent is effective for neuraminidase-resistant rotaviral infection in the individual.23 cl, 2 dwg, 12 tbl, 2 ex |
